Cargando…

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Lee, Yu Rim, Park, Soo Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612283/ https://www.ncbi.nlm.nih.gov/pubmed/26526818 http://dx.doi.org/10.3350/cmh.2015.21.3.230

Ejemplares similares

Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2015)

Influence of P53 on the radiotherapy response of hepatocellular carcinoma
por: Gomes, Ana R., et al.
Publicado: (2015)

Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people.
por: Lee, Shi Nae, et al.
Publicado: (2002)

Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
por: Choudhary, Heena B, et al.
Publicado: (2023)

Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2020)

TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma
por: Nikolova, Dafina, et al.
Publicado: (2018)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Regulatory T Cells in Radiotherapeutic Responses
por: Schaue, Dörthe, et al.
Publicado: (2012)

p53-Bad* in a Hepatocellular Carcinoma Mouse Model
por: Bowman, Katherine Redd, et al.
Publicado: (2023)

Noninvasive diagnostic criteria for hepatocellular carcinoma
por: Lee, Han Chu
Publicado: (2012)

Welcome to Journal of Hepatocellular Carcinoma
por: Kaseb, Ahmed O
Publicado: (2015)

Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Hot topics in hepatocellular carcinoma
por: Ielasi, Luca, et al.
Publicado: (2019)

Relationship of the expression levels of XIAP and p53 genes in hepatocellular carcinoma and the prognosis of patients
por: Li, Zhiqin, et al.
Publicado: (2017)

p53 expression is associated with tumor stage, grade and subtype in patients with hepatocellular carcinoma
por: Rahadiani, Nur, et al.
Publicado: (2023)

Clinical significance of lncRNA-ATB expression in human hepatocellular carcinoma
por: Jang, Se Young, et al.
Publicado: (2017)

Nonzero Risk of Hepatocellular Carcinoma Even after Sustained Virological Response
por: Lee, Hyun Woong
Publicado: (2016)

Surveillance for hepatocellular carcinoma: It is time to move forward
por: Kim, Bo Hyun, et al.
Publicado: (2022)

Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
por: Choi, Y. L., et al.
Publicado: (2001)

Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Hepatocellular Carcinoma
por: Joo, Young-Eun, et al.
Publicado: (2000)

Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1–p53 signaling
por: Jin, Hao, et al.
Publicado: (2017)

DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53
por: Zhang, Zhengdong, et al.
Publicado: (2016)

New potential instrument to fight hepatocellular cancer by restoring p53
por: Vincent, Franklin C., et al.
Publicado: (2011)

A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
por: Lee, Yu Rim
Publicado: (2023)

Pro-senescence therapy for hepatocellular carcinoma
por: Muehlich, Susanne, et al.
Publicado: (2013)

Role of ncRNAs in Hepatocellular Carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2018)

The Quest for Relevant Hepatocellular Carcinoma Biomarkers
por: Kim, Jin U., et al.
Publicado: (2017)

Hepatocellular Carcinoma: Special Issue Highlights
por: Gupta, Medhavi, et al.
Publicado: (2020)

Combination of biomarkers for the detection of hepatocellular carcinoma
por: Sternby Eilard, Malin, et al.
Publicado: (2020)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma
por: Numata, Kazushi
Publicado: (2021)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study
por: Wang, Zhi, et al.
Publicado: (2015)

Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
por: Krstic, Jelena, et al.
Publicado: (2022)

Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
por: Yang, Taewoo, et al.
Publicado: (2019)

Role of Periostin in Hepatocellular Carcinoma: The Importance of Tumor Microenvironment
por: Lee, Jung Il
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bvkdidp3kslnvof2j3qje8o5nu